Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Mahamaya Lifesciences Ltd (NSE: MAHALIFE), ISIN INE0U9D01019 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MAHALIFE last traded at ₹180.05 (-2.39%), with a 52-week range of ₹111.00 to ₹205.05 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 56.39%, FIIs 2.66%, DIIs 2.01%, mutual funds 0.00%.
EquiSense Score (ECS): 64/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.